|
|
||||||||
From the Departments of Neurology (Drs. Esselink, de Bie, and Speelman, and H.M.M. Smeding), Clinical Epidemiology and Biostatistics (Dr. de Haan), and Neurosurgery (Drs. Schuurman and Bosch), Academic Medical Center, Amsterdam; Department of Neurosurgery (Dr. Lenders), Medical Spectrum Twente, Enschede; Department of Neurology (Dr. Nijssen), St Elisabeth Hospital, Tilburg; and Department of Neurosurgery (Dr. Staal), Academic Hospital Groningen, the Netherlands.
Address correspondence and reprint requests to Dr. J.D. Speelman, Department of Neurology, Academic Medical Center, PO Box 22660, 1100 DD Amsterdam, the Netherlands; e-mail: J.D.Speelman{at}amc.uva.nl
Objective: To compare the efficacy of unilateral pallidotomy and bilateral subthalamic nucleus (STN) stimulation in patients with advanced Parkinson disease (PD) in a randomized, observer-blind, multicenter trial.
Methods: Thirty-four patients with advanced PD were randomly assigned to have unilateral pallidotomy or bilateral STN stimulation. The primary outcome was the change from baseline to 6 months in the motor part of the Unified PD Rating Scale (motor UPDRS) in the off phase. Secondary outcomes were parkinsonian symptoms in the on phase (motor UPDRS), dyskinesias (Clinical Dyskinesia Rating Scale and dyskinesias UPDRS), functional status (activities of daily living UPDRS and Schwab and England scale), PD Quality of Life questionnaire, changes in drug treatment, and adverse effects.
Results: The off phase motor UPDRS score improved from 46.5 to 37 points in the group of pallidotomy patients and from 51.5 to 26.5 in the STN stimulation patients (p = 0.002). Of the secondary outcome measures, on phase motor UPDRS and dyskinesias UPDRS improved significantly in favor of the STN stimulation patients. Reduction of antiparkinsonian drugs was greater after STN stimulation than after pallidotomy. One patient in each group had a major adverse effect.
Conclusions: Bilateral STN stimulation is more effective than unilateral pallidotomy in reducing parkinsonian symptoms in patients with advanced PD.
Received March 12, 2003. Accepted in final form September 8, 2003.
Dr. Esselink is currently affiliated with the University Medical Center, Nijmegen, the Netherlands.
J.D.S. acts as an independent consultant for Medtronic Ltd. (Minneapolis). An unrestricted research grant was received from Medtronic Ltd. for the workgroup Movement Disorders at the Academic Medical Center, University of Amsterdam. All authors received travel grants from Medtronic Ltd. to participate in scientific meetings, except for D.A.B. and R.J.H.
This article has been cited by other articles:
![]() |
D. Verbaan, S. Boesveldt, S. M. van Rooden, M. Visser, J. Marinus, M. G. Macedo, Y. Fang, P. Heutink, H. W. Berendse, and J. J. van Hilten Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics? Neurology, December 2, 2008; 71(23): 1877 - 1882. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Muslimovic, B. Post, J. D. Speelman, B. Schmand, R. J. de Haan, and For the CARPA Study Group Determinants of disability and quality of life in mild to moderate Parkinson disease Neurology, June 3, 2008; 70(23): 2241 - 2247. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Muslimovic, B. Post, J. D. Speelman, and B. Schmand Motor procedural learning in Parkinson's disease Brain, November 1, 2007; 130(11): 2887 - 2897. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.M.M. Smeding, J. D. Speelman, M. Koning-Haanstra, P. R. Schuurman, P. Nijssen, T. van Laar, and B. Schmand Neuropsychological effects of bilateral STN stimulation in Parkinson disease: A controlled study Neurology, June 27, 2006; 66(12): 1830 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pahwa, S. A. Factor, K. E. Lyons, W. G. Ondo, G. Gronseth, H. Bronte-Stewart, M. Hallett, J. Miyasaki, J. Stevens, and W. J. Weiner Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, April 11, 2006; 66(7): 983 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.M.J. Foncke, P. R. Schuurman, and J. D. Speelman Suicide after deep brain stimulation of the internal globus pallidus for dystonia Neurology, January 10, 2006; 66(1): 142 - 143. [Full Text] [PDF] |
||||
![]() |
N. Fogelson, D. Williams, M. Tijssen, G. van Bruggen, H. Speelman, and P. Brown Different Functional Loops between Cerebral Cortex and the Subthalmic Area in Parkinson's Disease Cereb Cortex, January 1, 2006; 16(1): 64 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Muslimovic, B. Post, J. D. Speelman, and B. Schmand Cognitive profile of patients with newly diagnosed Parkinson disease Neurology, October 25, 2005; 65(8): 1239 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Diamond and J Jankovic The effect of deep brain stimulation on quality of life in movement disorders J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1188 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
Subthalamic Deep Brain Stimulation vs. Pallidotomy for Advanced PD Journal Watch Neurology, April 9, 2004; 2004(409): 10 - 10. [Full Text] |
||||
![]() |
R. Pahwa, S. A. Factor, K. E. Lyons, W. G. Ondo, G. Gronseth, H. Bronte-Stewart, M. Hallett, J. Miyasaki, J. Stevens, and W. J. Weiner Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, April 11, 2006; 66(7): 983 - 995. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |